Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory and Cardiovascular Biomarkers in Healthy, Older Individuals.

The objective of this study is to understand the impact of a multi-botanical formulation on measurements of protein markers, with a focus on inflammation over a 60-day period. The primary objective of this study is to assess the effect of the formulation, LLP-01, on inflammatory and cardiovascular proteomic biomarkers. Adverse events will be self-monitored by participants and will be reported. Changes in weight/calculated BMI and grip strength, as well as changes in well-being through a self-reported questionnaire will also be measured.

Inclusion criteria

• Age: 50-75 years of age
• Any sex / gender
• All ethnicities
• Able to participate in a 2 month trial
• Able to provide informed consent
• Participant must be able to comply with treatment plan and laboratory tests
• Can swallow 00 size capsules

Exclusion criteria

• Any clinically diagnosed medical disease or disorder that requires prescribed medication(s)
• Currently on any anticoagulant medicines, such as warfarin
• Planned surgical procedure during study period
• Consumption of any supplements within the last 30 days that include the following botanicals/ingredients: green tea extract, Ashwagandha, Fisetin, Curcumin/Turmeric extract, Rosemary extract, Cordyceps, Ginseng
• Allergy or other sensitivity to any of the botanicals in the investigated product
• Currently or have been sick (bacterial or viral infection) in the last 14 days
• Alcoholism or drug addiction
• Participation in a clinical research trial within 30 days prior to enrollment in this trial
• Cognitive impairment, illiteracy, inability or unwillingness to give voluntary informed consent
• Unable or unwilling to provide required blood sample for testing and for use in a scientific publication (personal information undisclosed)
• Participants with any condition that may preclude venipuncture/ venous blood draw